Bapten Discontinued By PR Pharmaceuticals

The equine tendon medication Bapten has been discontinued by its manufacturer, PR Pharmaceuticals, because of a lack of demand for the product. The expense and length of treatment involved with Bapten therapy kept the drug from becoming popular with horse owners, according to Keri Nightingale, the company's marketing manager for Bapten.

"It requires a bit of a commitment on the horse

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners